A Malvern biotechnology company, Aclaris Therapeutics, said Friday that its drug to treat a common skin condition called seborrheic keratoses was approved by the U.S. Food and Drug Administration.
The hydrogen peroxide solution, which is administered in a pen-type applicator in a physician’s office, dissolves the growths.
